Fate Therapeutics (FATE) Other Non Operating Income (2012 - 2026)

Fate Therapeutics (FATE) has 14 years of Other Non Operating Income data on file, last reported at $2.5 million in Q3 2025.

• Quarterly Other Non Operating Income fell 47.12% year-over-year to $2.5 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 87.37% YoY) and the FY2025 annual result came in at $93000.0, down 98.43% from the prior year.
• Other Non Operating Income climbed to $2.5 million in Q3 2025, from $50000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $26.1 million in Q4 2022 to a low of -$15.7 million in Q4 2023.
• A 5-year average of $4.9 million and a median of $4.9 million in 2021 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 3972.67% in 2023, down 160.22% in 2023.
• Tracing FATE's Other Non Operating Income over 5 years: stood at $4.8 million in 2021, then surged by 439.93% to $26.1 million in 2022, then plunged by 160.22% to -$15.7 million in 2023, then soared by 132.07% to $5.1 million in 2024, then plunged by 50.8% to $2.5 million in 2025.
• The last three Other Non Operating Income figures came in at $2.5 million (Q3 2025), $50000.0 (Q2 2025), and $3.7 million (Q1 2025), per Business Quant data.